FSUE Endopharm presented new developments in the portfolio of medicines for veterinary use at XXXI Moscow International Veterinary Congress.
More than 5,000 people attended the three-day event, including more than 3,500 veterinarians and specialists on small domesticated animal. Over 350 highly qualified Russian and foreign lecturers provided a rich scientific and business program of the Veterinary Congress. Experts discussed actual trends and problems in modern veterinary medicine: from the medicines market and control measures by the Rosselkhoznadzor to foreign experience of Thai colleagues.
Eduard Arutyunov, Deputy Director General for Sales of FSUE Endopharm, within the “Business and Government” Congress section, presented up-to-date information on control measures in relation to potent veterinary drugs and drugs containing narcotic drugs and psychotropic substances to veterinary specialists.
Last year, the Enterprise received a conclusion on the compliance of the manufacturer of medicines for veterinary use with the requirements of EEU GMP rules, and also released the first veterinary drug in its portfolio “Tramvet” (INN – tramadol hydrochloride), an analgesic with a mixed mechanism of action. The medicine is used as an anesthetic for moderate and severe pain (postoperative period, trauma, diagnostic or therapeutic procedures, including dental, and other non-infectious diseases accompanied by pain) as part of complex therapy for dogs and cats.
This year, in June, it is planned to introduce Ketamine-ENDOPHARM intended for non-inhalation general anesthesia of animals, the second veterinary medicine manufactured by FSUE Endopharm, into civilian circulation.
“The first series of the medicine have already been produced, two of them are now sent to an independent accredited laboratory. After passing quality control, the veterinary medicine will be introduced into civil circulation,” said Eduard Arutyunov.
Ketamine-ENDOPHARM is intended for non-inhalation general anesthesia of domesticated dogs and cats in all types of operations and painful diagnostic procedures. This is the first domestic psychotropic veterinary medicine included in the second list of the National List of Narcotic Drugs and Psychotropic Substances. Veterinary organizations need to obtain an appropriate license for its circulation (acquisition, transportation, storage, release within its organizational structure, use and (or) destruction).
A special subsection on the site www.endopharm.ru is developed for assisting veterinarians, which is regularly filled with useful information. The subsection contains clarifications on issuing a license for the circulation of narcotic drugs and psychotropic substances, as well as on circulation of the Tramvet preparation. Logged-in users can ask questions and consult with the specialists of FSUE Endopharm, who have many years of experience in the field of circulation of narcotic drugs, psychotropic and potent substances, as well as experts of a specially formed Expert Council on Legal Drug Circulation, whose activities are provided by an autonomous non-profit organization established by FSUE Endopharm.
In 2023, the Enterprise plans to introduce into production “Diazepam-ENDOPHARM”, a new medicinal product for veterinary use. This is a potent tranquilizer belonging to the third List of Narcotic Drugs and Psychotropic Substances, which is in demand in veterinary medicine and for transporting large animals.
Also in the current year, it is planned to register other veterinary medicines, such as the direct-acting anticoagulant Sodium Heparin-ENDOPHARM, the alpha- and beta- adrenergic agonist Epinephrine-ENDOPHARM, and the antiemetic Metoclopramide-ENDOPHARM.
Medicines for animals are a promising and demanded line of work of the Enterprise aimed at ensuring the availability of the necessary veterinary medicines. The production facilities of FSUE Endopharm also allow producing veterinary medicines in a wide range of dosage forms under contract manufacturing. The presence of an accredited testing laboratory is an additional advantage of the Enterprise, the scope of which includes quality control of veterinary medicines.
Comment type is not specified in the component properties.